Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
July 26, 2008
 
Industry Categories  
News by Country  
News by MSA  
Todays News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
Close Move
All Press Releases for March 15, 2007 Subscribe to this News Feed      
 

Ambien Class Action Gets FDA Support: FDA Directs Sanofi-Aventis to Warn Consumers About Sleep Eating and Sleep Driving

On March 6, 2006, Susan Chana Lask, Counsel for the Ambien Consumers, Filed the Federal Class Action for Better Warnings & Relief is Now in Sight

New York, NY (PRWEB) March 15, 2007 -- New York City Attorney Susan Chana Lask filed a class action complaint (www.appellate-brief.com/media/AmbienClassAct.html) in the Southern District of New York on March 6, 2006, Index No. 06CV1672, maintaining the warnings by Sanofi Aventis were inadequate. Today she has a major victory on her side for her class of thousands of people nationwide - the FDA in a March 14, 2007 news release informs it has directed Sanofi-Aventis to strengthen warnings on their labels about the two rare but serious side effects that Ms. Lask's class complaint alleged since last year:

-Complex sleep-related behaviors which may include sleep-driving, making phone calls, and preparing and eating food (while asleep).

The purpose of our lawsuit was to insure Ambien warns consumers and doctors about the potential side effects of sleep walking and sleep eating because it is unfair for this huge manufacturer to make billions from the 26 million or so prescriptions of their product a year and not provide that simple warning. Clearly the FDA agreed with my position.
The FDA directed the manufacturer to write letters to doctors to notify them of the new warnings, and all prescription sleeping pills now will come with special brochures called "Medication Guides" that spell out the risks for patients in easy-to-understand language. The FDA website explains more for consumers.

Ms. Lask made public these dangerous side effects last year by her filing of the class Action and her subsequent campaign to get stronger warnings for consumers who became what she termed "Ambien Zombies". Ms. Lask's Complaint alleged that taking Ambien for a good night's sleep did not happen as advertised for many consumers, but instead they woke up only to find themselves in jail, driving cars while in a hypnotic state and binge eating at night while their spouses shoveled food from their mouths.

Attorney Susan Chana Lask explains, "The purpose of our lawsuit was to insure Ambien warns consumers and doctors about the potential side effects of sleep walking and sleep eating because it is unfair for this huge manufacturer to make billions from the 26 million or so prescriptions of their product a year and not provide that simple warning. Clearly the FDA agreed with my position."
      
A press conference will be held Thursday, March 15, 2007 at 10 A.M. at the Southern District of New York Courthouse steps at Centre Street, New York City where the press can view thousands of the complaints in this action, get details of the class action and get up to date information regarding the action and what will occur next for consumers nationwide.

###

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/TWFnbi1Db3VwLVByb2YtU3VtbS1NYWduLVplcm8=

Technorati Tags

Bookmark -  Del.icio.us | Digg | Furl It | Spurl | RawSugar | Simpy | Shadows | Blink It | My Web


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareIt

Share The News

Submit this press release easily to any of these major bookmarking and social media sites.

CONTACT INFORMATION
SUSAN CHANA LASK, ESQ.
212.358-5762
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your login.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these releases. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright